Protalix BioTherapeutics (PLX) Cash & Current Investments (2010 - 2026)
Protalix BioTherapeutics (PLX) posted Cash & Current Investments of $40.66 million for Q2 2026, up 21.7% from $33.4 million a year earlier but down 20.4% from the prior quarter.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) Cash & Current Investments (2010 - 2026) Analysis & Trends
At the end of FY2025, Protalix BioTherapeutics' Cash & Current Investments came in at $30.27 million, down 13.1% from FY2024.
- Annual Cash & Current Investments shows a five-year compound annual growth rate of -4.7% (FY2020 to FY2025).
- In prior years, Protalix BioTherapeutics' Cash & Current Investments was $34.83 million in FY2024 (-21.8%), $44.56 million in FY2023 (+100.9%), $22.18 million in FY2022 (-43.1%) and $38.99 million in FY2021 (+1.1%).
- Quarterly Cash & Current Investments has run from a low of $20.81 million in Q3 2022 to a high of $51.08 million in Q1 2026 over five years.
- On a year-over-year basis, Cash & Current Investments increased in three of the last eight quarters, with an average decline of 5.8%.
- The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q4 2023, with growth of 100.9%; the weakest was Q2 2022, with a decline of 62.9%.
- According to Business Quant data, Cash & Current Investments for the three prior quarters was $51.08 million (Q1 2026), $30.27 million (Q4 2025) and $29.37 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Protalix BioTherapeutics | 200.77 Mn | 49.38 Mn | 12.13 Mn | 40.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 40.66 Mn |
| Mar 31, 2026 | 51.08 Mn |
| Dec 31, 2025 | 30.27 Mn |
| Sep 30, 2025 | 29.37 Mn |
| Jun 30, 2025 | 33.40 Mn |
| Mar 31, 2025 | 34.74 Mn |
| Dec 31, 2024 | 34.83 Mn |
| Sep 30, 2024 | 27.41 Mn |
| Jun 30, 2024 | 45.03 Mn |
| Mar 31, 2024 | 48.49 Mn |
| Dec 31, 2023 | 44.56 Mn |
| Sep 30, 2023 | 40.98 Mn |
| Jun 30, 2023 | 48.18 Mn |
| Mar 31, 2023 | 33.04 Mn |
| Dec 31, 2022 | 22.18 Mn |
| Sep 30, 2022 | 20.81 Mn |
| Jun 30, 2022 | 28.57 Mn |
| Mar 31, 2022 | 32.92 Mn |
| Dec 31, 2021 | 38.99 Mn |
| Sep 30, 2021 | 48.66 Mn |
API Access
Protalix BioTherapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=PLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();